These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6447827)

  • 1. [Activity of proteolytic enzymes contaminating human placental immunoglobulin preparations].
    Iskierko J; Zarnowski J
    Med Dosw Mikrobiol; 1980; 32(1):63-8. PubMed ID: 6447827
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the gonadotropic activity of human immunoglobulin preparations of the placental origin].
    Aleksandrowicz J; Banach W
    Med Dosw Mikrobiol; 1983; 35(1):65-9. PubMed ID: 6633034
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the degree of degradation of human placental immunoglobulin preparations].
    Aleksandrowicz J; Zakrzewska A
    Med Dosw Mikrobiol; 1983; 35(3-4):269-75. PubMed ID: 6374336
    [No Abstract]   [Full Text] [Related]  

  • 4. [New method of deriving fibrinolysin preparations].
    Kanygina EL; Andreenko GV
    Vopr Med Khim; 1966; 12(5):555-6. PubMed ID: 4233543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoglobulins in placental tissue].
    Vŭlcheva B; Matrova Ts; Rachev E
    Akush Ginekol (Sofiia); 1984; 23(6):498-500. PubMed ID: 6532228
    [No Abstract]   [Full Text] [Related]  

  • 6. [The structure of immunoglobulins and the problem of associated proteases].
    Robert B
    Prog Immunobiol Stand; 1970; 4():13-6. PubMed ID: 4099024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bacterial and viral antibodies in human immunoglobulin preparations. I. Bacterial antibodies].
    Sporzyńska Z; Albrycht H; Wysokińska T; Banach W; Bucholc B
    Med Dosw Mikrobiol; 1978; 30(3):141-8. PubMed ID: 713633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the stability of human immunoglobin preparations from the placenta].
    Aleksandrowicz J; Zakrzewska A
    Med Dosw Mikrobiol; 1981; 33(1):73-81. PubMed ID: 7278431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of placental immunoglobulin degradation by lyophilization].
    Iskierko J; Zarnowski J; Prasał Z
    Med Dosw Mikrobiol; 1980; 32(1):69-73. PubMed ID: 7412446
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the fluorescence in preparations of normal human immunoglobulin during deamidation].
    Lukash AI; Shepelev AP; Al'perovich DV; Pushkina NV; Sherstnev KB
    Antibiot Med Biotekhnol; 1986 Nov; 31(11):848-51. PubMed ID: 3813507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fc gamma receptor on human placental plasma membrane. I. Studies on the binding of homologous and heterologous immunoglobulin G1.
    van der Meulen JA; McNabb TC; Haeffner-Cavaillon N; Klein M; Dorrington KJ
    J Immunol; 1980 Feb; 124(2):500-7. PubMed ID: 6766159
    [No Abstract]   [Full Text] [Related]  

  • 12. [The content of gonadotropic hormones in commercial immunoglobulin preparations].
    Migunov VN; Pozina IM; Pavelkovskaia LG; Kotliarskaia EI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):64-8. PubMed ID: 665022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and immunohistochemical studies on the localization of immunoglobulins in porcine placenta.
    Yano K; Hashimoto Y; Kitagawa H; Kon Y; Kudo N
    Jpn J Vet Res; 1988 Oct; 36(3-4):205-21. PubMed ID: 3221607
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ratio of admixtures of blood group substances and heme pigments in immunoglobulin preparations from different types of raw material].
    Migunov VN; Pozina IM; Minakova LV; Kozlova NE; Gavrilenkova VIu
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jun; (6):98-100. PubMed ID: 7113533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological study on placenta from pregnancies with systemic lupus erythematosus].
    Di W; Hong SY; Yan JH
    Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):708-10, 760. PubMed ID: 7712895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biologically active substances, other than antibodies, in preparations of normal human immunoglobulin. II. Placental proteins].
    Banach W
    Med Dosw Mikrobiol; 1986; 38(4):249-56. PubMed ID: 3561099
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factors influencing the degradation and aggregation of human immunoglobulin preparations].
    Aleksandrowicz J; Zakrzewska A; Mierzejewska H
    Med Dosw Mikrobiol; 1973; 25(3):287-99. PubMed ID: 4271435
    [No Abstract]   [Full Text] [Related]  

  • 18. The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans.
    Ben-Hur H; Gurevich P; Berman V; Tchanyshev R; Gurevich E; Zusman I
    In Vivo; 2001; 15(5):429-35. PubMed ID: 11695242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin.
    Palmeira P; Costa-Carvalho BT; Arslanian C; Pontes GN; Nagao AT; Carneiro-Sampaio MM
    Pediatr Allergy Immunol; 2009 Sep; 20(6):528-35. PubMed ID: 19220771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.
    Leach JL; Sedmak DD; Osborne JM; Rahill B; Lairmore MD; Anderson CL
    J Immunol; 1996 Oct; 157(8):3317-22. PubMed ID: 8871627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.